The DOI matches its Crossref record; 325 of the 326 references it cites were found in a registry or an index.
Mitochondrial dysfunction in Parkinson's disease
Open accessAbstract
Mitochondria are highly dynamic organelles which fulfill a plethora of functions. In addition to their prominent role in energy metabolism, mitochondria are intimately involved in various key cellular processes, such as the regulation of calcium homeostasis, stress response and cell death pathways. Thus, it is not surprising that an impairment of mitochondrial function results in cellular damage and is linked to aging and neurodegeneration. Many lines of evidence suggest that mitochondrial dysfunction plays a central role in the pathogenesis of Parkinson's disease (PD), starting in the early 1980s with the observation that an inhibitor of complex I of the electron transport chain can induce parkinsonism. Remarkably, recent research indicated that several PD-associated genes interface with pathways regulating mitochondrial function, morphology, and dynamics. In fact, sporadic and familial PD seem to converge at the level of mitochondrial integrity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recessively inherited loss-of-function mutations in PTEN-induced kinase 1 (PINK1) and the E3 ubiquitin ligase PRKN are the most common genetic causes for early-onset PD, which occurs in about 5%–10% of cases [1, 2].”
From miRNA family miR-29 inhibits PINK1-PRKN signaling via ATG9A (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Loss-of-function mutations in the genes encoding PINK1 and PRKN result in early-onset Parkinson disease (EOPD).”
From miRNA family miR-29 inhibits PINK1-PRKN signaling via ATG9A (2026) · cites this paper as [2]
In the citing paper
“α-Synuclein has been reported to cause dysfunction of mitochondrial complex I in PD which in turn increases levels of ROS and consequently ROS-induced oxidative stress (Winklhofer and Haass 2010).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Winklhofer and Haass 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Flagged first, then by citations
1 of the 326 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–690 of 690
Neurodegenerative Diseases and Succinate Dehydrogenase: A Therapeutics Avenue for Treatment
Viswalingam, V., & Kumar, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_9 · Cited by 1
Artificial intelligence and multiomics integration for Parkinson’s disease drug development
Lee, S., Kim, J., Jung, H., Kim, D., Cho, E., Kim, Y.-J., Ji, Y. R., Go, Y., Song, P., Oh, Y., et al. (2026) · Molecules and Cells · doi:10.1016/j.mocell.2026.100343 · Cited by 2
Mitochondrial Fission-Fusion and Parkinson’s Disease: A Dynamic Question of Compensatory Networks
Chu, C. T., & Berman, S. (2011) · Springer eBooks · doi:10.1007/978-94-007-1291-1_7 · Cited by 1
“The recent discoveries that several PD-linked gene products exhibit regulated translocation to mitochondria have stimulated a renaissance of interest in mitochondrial dysfunction as a primary mechanism in parkinsonian neurodegeneration (Reviewed in (Winklhofer and Haass 2010)).”
BackgroundMitochondrial Therapeutic Approaches in Parkinson’s Disease
Esteves, A. R., Silva, D. F., G-Fernandes, M., Gomes, R., & Cardoso, S. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_9 · Cited by 1
Parkinson’s Disease in Humans and in Nonhuman Primate Aging and Neurotoxin Models
Metzger, J. M., Jones, C. A., & Emborg, M. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00046-4 · Cited by 1
Identification of potential Parkinson’s disease biomarkers using computational biology approaches
Chowdhury, H. A., Barah, P., Bhattacharyya, D. K., & Kalita, J. K. (2021) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-020-00280-5 · Cited by 1
HSF Inhibits the Progression of Age-Related Neurodegenerative Diseases
Kondo, N., Katsuno, M., Riku, Y., & Sobue, G. (2016) · Springer eBooks · doi:10.1007/978-4-431-55852-1_11 · Cited by 1
Obata, T. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.01.053 · Cited by 1
Verma, M., Basu, S., Singh, M., Rachana, R., Kaur, S., & Goel, N. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch008 · Cited by 1
Zhao, J., Chen, Y., Zhi, L., Xu, Q., Zhang, H., & Li, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.17.602426 · Cited by 1
miRNA family miR-29 inhibits PINK1-PRKN signaling via ATG9A
Markham, B. N., Ramnarine, C., Kim, S., Grever, W. E., Soto-Beasley, A. I., Heckman, M. G., Ren, Y., Osborne, A. C., Kehili, M., Bhagwate, A. V., et al. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00029-w
Analysis of neuronal transcripts of PGC-1α transgenic mice
Döhla, J. M. (2013) · Työväentutkimus Vuosikirja
Iontophoretic delivery of selected antiparkinsonian agents in vitro
Giller, T. (2009) · The University of Bath Online Publications Store (The University of Bath)
Song, D. H. (2013) · Deep Blue (University of Michigan)
Mitochondrial DNA haplogroup-dependence of drugs and xenobiotics toxicity
Strobbe, D. (2014) · Padua@research (University of Padova)
Review Article Genetic Neuropathology of Parkinson’s Disease
Cookson, M., Hardy, J., & Lewis, P. A. (2007)
Role of Trichloroethylene in Parkinson’s Disease
Goldman, S. M., & Cash, S. W. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6311-4_6
HTRA2 (HtrA serine peptidase 2)
Jarząb, M., Żurawa‐Janicka, D., & Lipińska, B. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/47325
Oxidative Modification of Cytochrome c by Tetrahydropapaveroline, an Isoquinoline-Derived Neurotoxin
Kang, J. H. (2013) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2013.34.2.406
Recessive Parkinsonism, Mitochondria and Translational Regulation
Blackinton, J. G. (2008) · Figshare
Rinne, J. (2013) · Tampere University Institutional Repository (Tampere University)
Estudo das alterações motoras e comportamentais induzidas por rotenona em ratos machos e fêmeas
Ferreira, F. F. (2015) · UFPR Digital Collection (Federal University of Paraná)
Structural andT hermodynamic Studies of a-Synuclein Proteins Related to Parkinson’s Disease
(2011) · CRC Press eBooks · doi:10.1201/b10835-3
Nitric Oxide Synthase, Green Tea Catechins and Parkinson’s Disease
Kim, J. S., Oh, E., & Kim, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384937-3.00119-1
Nguyen, K. K. (2016) · Journal of Purdue Undergraduate Research · doi:10.5703/1288284316155
mitochondrial morphology, instability of mtDNA and senescence
Kato, A., Kurashima, K., Chae, M. S., Sawada, S., Hatakeyama, S., Tanaka, S., & Inoue, H. (2010)
A Review of Mathematical Models for Muscular Dystrophy: A Systems Biology ApproachPreprint
Cameron, A. N., Houston, M. T., & Gutiérrez, J. B. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1610.03521
Taram, F. (2016) · Digital Commons - DU (University of Denver)
Regulation of mitochondrial and nonmitochondrial protein turnover by the PINK1-Parkin pathway
Vincow, E. S. (2013) · ResearchWorks at the University of Washington (University of Washington)
de Araújo, G. W., & Beyer, C. (2012)
GDNF and Neurturin isoforms in an experimental model of Parkinson's disease
Penttinen, A. (2017) · Työväentutkimus Vuosikirja
Approach Towards The Development Of Novel Disease Modifying Therapeutics For Parkinson's Disease
Luo, D. (2017) · Human Biology
Development Of High-throughput 3d Neural Cell Culture Platforms For Modelling Parkinson’s Disease
Ko, K. R. (2017) · DalSpace (Dalhousie University)
Helicases and Their Relevance to Aging
Crouch, J. D., Banerjee, T., Awate, S., Bharti, S. K., & Brosh, R. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00072-5
Human Genomics of Complex Trait Severity
Kleinstein, S. E. (2017)
Li, W., Lozano‐Montes, L., Nair, J., Dimanico, M., Mazloum, R., Hu, Z., Scolari, B., Dengjel, J., Theilig, F., Harvey, M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/374256
Oligomeric α-Synuclein-Specific Degradation by HtrA2/Omi to Bestow a Neuroprotective FunctionPreprint
Chung, H., Jamal, M. A. H. M., Rahman, M. M., Kim, H., & Hong, S. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3258645
Natural and Synthetic GHSR1a Agonists as Neuroprotective Agents in Models of Parkinson's disease
Rees, D. J. (2017) · Cronfa (Swansea University) · doi:10.23889/suthesis.40946
Characterization of the Mitochondrial Peptide Pβ
Tan, W. G. (2018) · TSpace (University of Toronto)
The role of POLG mutations in human disease
Anagnostou, M. (2018)
Petruski‐Ivleva, N. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/j7sy-9s93
Dinesh, A. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13741
The Effects of Rifampicin on Neuronal Survival
Yurtsever, İ., & Emekli‐Alturfan, E. (2020) · Experimed · doi:10.26650/experimed.2019.19025
Multi-omics analysis of human brain tissue and an animal model of Parkinson’s Disease
Gomes, L. C. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7812
Masoud, S. T. (2017) · TSpace (University of Toronto)
Investigating cellular stress in industry and medicine
Hyland, R. A. (2012)
Kumari, B., Mandal, M., & Dholaniya, P. S. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100712
Machine learning discriminates parkinsonian movement disorders in zebrafish
Hughes, G. L. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Mohan Kumar, B. S., & Mahaboob Basha, P. (2020) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt20jun323
Neuropeptide cocaine- and amphetamine-regulated transcript usage in Parkinson's disease
Mao, P., & Mao, Y. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815946-0.00039-9
Causes and Consequences of Mitochondrial Variation in Caenorhabditid Nematodes
Hicks, K. A. (2000) · doi:10.15760/etd.928
“…ETC genes can have a variety of detrimental consequences that manifest at cellular, tissue, and whole organism levels (Wallace 1999; Schon and Manfredi 2003), and have been implicated in many complex human diseases (Grad et al. 2005; Haas 2010; Winklhofer and Haass 2010; Ienco et al. 2011).”
BackgroundYe, T. (2018) · UA Campus Repository (The University of Arizona)
Investigation of early assembly of OXPHOS complexes during mitochondrial translation
Wang, C. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8330
Hada, B., Karmacharya, M. B., Park, S. R., & Choi, B. H. (2021) · Free Radical Research · doi:10.1080/10715762.2021.2010730
“NADH dehydrogenase, and blocks proton pumping [5].”
Role of mitophagy in muscle growth and metabolism
Peker, N. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72691
Dana, S., Ghaedi, K., Peymani, M., & Nasr‐Esfahani, M. H. (2022) · Neurochemical Journal · doi:10.1134/s1819712422010056
Kachko, R., & LoGiudice, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00205-3
Mischley, L. K., Jennings, K., Bongiorno, P. B., & LoGiudice, P. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-2333-5.00196-6
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-388425-1.00023-3
Directing a messenger RNA into yeast mitochondria
Sunba, N. (2011) · doi:10.22215/etd/2011-09369
Interactions of Fibrillar Insulin with Proteins: A Molecular Docking Study
Trusova, V. M., Zhytniakivska, O. A., Tarabara, U. K., Vus, K. O., & Gorbenko, G. P. (2022) · East European Journal of Physics · doi:10.26565/2312-4334-2022-2-17
Colligation of Mitochondria Dysfunction and Neurodegeneration: Parkinson’s Disease
Amrutha, K., Yadav, N., & Singh, S. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010004
Teerapattarakan, N. (2018) · Chula Digiverse · doi:10.58837/chula.the.2018.433
Generating Models of Human Gait in Patients with Parkinson’s Disease using Genetic Programming
Navikevicius, T., Nóbrega, L. R., Houghten, S. K., Andrade, A. D. O., & Pereira, A. A. (2024) · IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) · doi:10.1109/cibcb58642.2024.10702158
“PD is categorized by resting tremor, rigidity, loss of movement (akinesia), slowness of movement (bradykinesia), and postural instability [28].”
BackgroundThe potential of brain organoids in addressing the heterogeneity of synucleinopathies
Diao, X.-J., Soto, C. A., Wang, F., Wang, Y., Wu, Y., & Mukherjee, A. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05686-w
“Subsequently, numerous familial mutations associated with PD across various genes, such as PARKIN , PINK1 , and DJ-1 , directly linked abnormalities in mitochondrial homeostasis and function to the disease's pathology [90].”
Malovytsia, U., Trusova, V. M., Thomsen, M. H., & Gorbenko, G. P. (2025) · East European Journal of Physics · doi:10.26565/2312-4334-2025-1-45
The role of antioxidant supplementation in neuronal disorders
ShamsEldeen, A. M., Ammar, H. I., Al-Hashem, F. H., Alrefaie, Z. A., Aly, M. H., & Hanna, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27333-9.00004-x
Ahlberg, C. D. (2014) · DigitalCommons (California Polytechnic State University)
Signal Transduction Pathways Modulated by the PD-causative Gene LRRK2
Carballo‐Carbajal, I. (2009)
Kharrati-Koopaee, H., Ebrahimie, E., Dadpasand, M., Niazi, A., Tian, R., & Esmailizadeh, A. (2021) · Figshare · doi:10.6084/m9.figshare.14936331
Kharrati-Koopaee, H., Ebrahimie, E., Dadpasand, M., Niazi, A., Tian, R., & Esmailizadeh, A. (2021) · Figshare · doi:10.6084/m9.figshare.14936334
Ghosh, A. (2012) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-1769
Quercetin and Curcumin’s Potential Defenses Against Rotenone-induced Parkinson’s disease in Rats
Lard, M., deol, S., Dhanawat, M., Gupta, N., Bansal, S., Bhatia, M., Morsy, M. A., Nair, A. B., Krishan, P., Gupta, S., et al. (2026) · Current Nutrition & Food Science · doi:10.2174/0115734013378452251021013702
Herrera, C. L. (2015) · theses.fr (ABES) · doi:10.70675/d09d7e9cz079fz4faaz985aza9cd4fc18f18
van Hameren, G. (2018) · theses.fr (ABES) · doi:10.70675/71c15a42zb6d9z4edazb7c1zd3f51e09c949
Comorbidities in Age-Related Cataract: Epidemiological Burden and Public Health Implications
Ripa, M., Forlini, M., Schipa, C., & Shah, N. A. (2026) · Vision · doi:10.3390/vision10020024
“Thus, mitochondrial dysfunction may partially contribute to the development of cataracts and Parkinson’s disease [96].”
Baggiani, M., Giacich, M., Naef, V., Santorelli, F. M., & Damiani, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731096
Bhattacharjee, S. (2026) · Advanced Materials Interfaces · doi:10.1002/admi.70595
Arias-Carrión, Ó., Guerra‐Crespo, M., Soto-Rojas, L. O., Valle, Y., Ortega‐Robles, E., & Ortuño‐Sahagún, D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1886917 · Cited by 2
“Several studies support direct interaction and reciprocal modification, whereas others find no such evidence, reflecting methodological differences and the dynamic nature of the PINK1–parkin complex (Winklhofer and Haass, 2010).”
Quality control of proteins and organelles by autophagy
Mizushima, N. (2012) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-27928-7_6
Metadata
- Authors
- Winklhofer, K. F., & Haass, C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Winklhofer, Konstanze F.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 1802
- Issue
- 1
- Pages
- 29-44
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2130497877
- Cited by
- 688
- References
- 326
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 13 · 2023: 27 · 2022: 30 · 2021: 37 · 2020: 55 · 2019: 38 · 2018: 72 · 2017: 51 · 2016: 61 · 2015: 39 · 2014: 29 · 2013: 37 · 2012: 49
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 596)
- German Ministry for Education and Research
- the Helmholtz Alliance “Mental Health in an Ageing Society,”
- the Center for Integrated Protein Science Munich
- the Hans and Ilse Breuer Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mitochondrial dysfunction, Parkinson's disease, mitochondrial dynamics, mitochondrial morphology, mitochondrial complex I inhibition, parkinsonism, electron transport chain, calcium homeostasis, stress response, cell death pathways, neurodegeneration, aging, familial Parkinson's disease, sporadic Parkinson's disease
- MeSH terms
- Animals, DNA, Mitochondrial, Humans, Mitochondria, Models, Biological, Parkinson Disease, Oxidative Stress, Mitochondrial Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review